Circio

Develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

HQ location

Oslo, Norway

Website

Launch date

2010

Employees

Market cap

Enterprise value

($2m)

Share price

NOK0.65 TRVX.OL

Company register number

996162095

Recent deals

Oncos Therapeutics

https://twitter.com/targovax https://www.linkedin.com/company/circio/

Authorizing premium user...